Back

Introduction - PCSK9 inhibitors: the evidence-based story.

29 August 2017 (12:45 - 12:50)
Organised by:
Congress Presentation Part of: PCSK9 inhibitors: the evidence-based story Atherosclerosis Open Access ESC Congress 2017

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
The LDL-C paradigm.
Professor B. Ference (Cambridge, GB)
Video
Presentation thumbnail
Atherosclerosis regression and low LDL-C.
Professor S. Nicholls (Melbourne, AU)
Slides Video
Presentation thumbnail
Evidence for CV event reduction with lower LDL-C.
Professor C. Packard (Glasgow, GB)
Video
Presentation thumbnail
Panel discussion - PCSK9 inhibitors: the evidence-based story.
Professor K. Ray (London, GB)
Video
Presentation thumbnail
What questions remain unanswered?
Professor K. Ray (London, GB)
Video

Access the full session

Session thumbnail
PCSK9 inhibitors: the evidence-based story

The Event

Event poster

ESC Congress 2017

29 August 2017 12:45 CET
You may be interested in
thumbnail
Congress Presentation
Evaluating risk-based allocation strategies for PCSK9 inhibitors: results from a simulation study in a contemporary ASCVD cohort
26 August 2023
thumbnail
Congress Presentation
Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia
2 September 2019
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024
thumbnail
Congress Presentation
PCSK9 inhibitors and incidence of arrhythmias in clinical practice: a phase IV multicentric study
18 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources